PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26879328-0	2016	Azilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activity.	azilsartan	0-10	angiotensin II, type I receptor-associated protein	Mus musculus	15-45	
26879328-3	2016	The goal of this study is to investigate whether azilsartan, an AT1-R blocker, could attenuate oxidative injury in endothelial cells via regulating mitochondrial function and inflammatory responses.	azilsartan	49-59	angiotensin II, type I receptor-associated protein	Mus musculus	64-69	
26879328-10	2016	Overall, our data suggest that the AT1-R blocker azilsartan may have therapeutic values in treating endothelial dysfunction associated neurological disorders through anti-oxidative and anti-inflammatory properties.	azilsartan	49-59	angiotensin II, type I receptor-associated protein	Mus musculus	35-40